Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGAM | O43451 | 7/20 | 0.73 |
| ▸ | SI | P14410 | 6/20 | 0.73 |
| ▸ | AMY2A | P04746 | 8/20 | 0.70 |
| ▸ | GAA | P10253 | 4/20 | 0.69 |
| ▸ | AMY1A | P0DUB6 | 2/20 | 0.69 |
| ▸ | CNR1 | P21554 | 1/20 | 0.69 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.69 |
| ▸ | PDE4A | P27815 | 1/20 | 0.69 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.69 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.69 |
| ▸ | GLA | P06280 | 1/20 | 0.69 |
| ▸ | TREH | O43280 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14223717 | 1.00 | MGAM (0.73) | MGAMSIAMY2AGAAAMY1A | |
| SCHEMBL14408998 | 1.00 | MGAM (0.73) | MGAMSIAMY2AGAAAMY1A | |
| SCHEMBL14193754 | 1.00 | MGAM (0.73) | MGAMSIAMY2AGAAAMY1A | |
| SCHEMBL14408902 | 0.86 | MGAM (0.62) | MGAMSIAMY2AGAAAMY1A | |
| SCHEMBL14408901 | 0.86 | MGAM (0.72) | MGAMSIAMY2AGAAAMY1A | |
| SCHEMBL14408731 | 0.84 | MGAM (1.00) | MGAMSIAMY2AGAAAMY1A | |
| SCHEMBL5158956 | 0.84 | MGAM (1.00) | MGAMSIAMY2AGAAAMY1A | |
| SCHEMBL14408602 | 0.84 | MGAM (1.00) | MGAMSIAMY2AGAAAMY1A | |
| SCHEMBL14408606 | 0.84 | MGAM (1.00) | MGAMSIAMY2AGAAAMY1A | |
| SCHEMBL14408476 | 0.84 | MGAM (1.00) | MGAMSIAMY2AGAAAMY1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4062950-A | SACCHARASE AND AMYLASE INHIBITORS | BAYER AKTIENGESELLSCHAFT (DT) | 1977-12-13 | — | — | US | claimed |
| US-20090041740-A1 | CANCER TREATMENT BY METABOLIC MODULATIONS | ENGENE, INC. (CA) | 2009-02-12 | — | — | US | disclosed |
| US-20050202559-A1 | Cancer treatment by metabolic modulations | HERCULES CAPITAL, INC. | 2005-09-15 | — | — | US | disclosed |
| US-4065557-A | GLUCOPYRANOSE DERIVATIVES | BAYER AKTIENGESELLSCHAFT (DT) | 1977-12-27 | — | — | US | disclosed |
| US-4062950-A | SACCHARASE AND AMYLASE INHIBITORS | BAYER AKTIENGESELLSCHAFT (DT) | 1977-12-13 | — | — | US | disclosed |